Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Basik

Showing results (41-50 of 130) with videos related to

Pageof 13
Sort By:
Breast Cancer Research and Treatment|September 23, 2016
Inhibition of EGFR, HER2, and HER3 signaling with AZD8931 in combination with anastrozole as an anticancer approach: Phase II randomized study in women with endocrine-therapy-naïve advanced breast cancerStephen Johnston, Mark Basik, Roberto Hegg, et al.
Journal of Proteome Research|February 7, 2015
Glycoproteomic comparison of clinical triple-negative and luminal breast tumorsJennifer J Hill, Tammy-Lynn Tremblay, François Fauteux, et al.
Frontiers in Pharmacology|October 19, 2011
Resistance to cancer treatment: the role of somatic genetic events and the challenges for targeted therapiesGerald Batist, Jian Hui Wu, Alan Spatz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 3, 2019
A Study of Pre-Analytical Variables and Optimization of Extraction Method for Circulating Tumor DNA Measurements by Digital Droplet PCRLuca Cavallone, Mohammed Aldamry, Josiane Lafleur, et al.
Cancer|December 17, 2021
Clinicopathologic features of breast cancers diagnosed in women treated with prior radiation therapy for Hodgkin lymphoma: Results from a population-based cohortStephanie M Wong, Lissa Ajjamada, Anna C Weiss, et al.
Annals of Surgical Oncology|October 23, 2020
Oncologic Safety of Sentinel Lymph Node Biopsy Alone After Neoadjuvant Chemotherapy for Breast CancerStephanie M Wong, Mark Basik, Livia Florianova, et al.
Annals of Surgical Oncology|August 3, 2017
Nonoperative Management for Invasive Breast Cancer After Neoadjuvant Systemic Therapy: Conceptual Basis and Fundamental International Feasibility Clinical TrialsHenry M Kuerer, Marie-Jeanne T F D Vrancken Peeters, Daniel W Rea, et al.
Human Mutation|February 5, 2013
Making sense of intratumor genetic heterogeneity: altered frequency of androgen receptor CAG repeat length variants in breast cancer tissuesBruce Gottlieb, Carlos Alvarado, Chunlin Wang, et al.
Cancers|April 3, 2021
Early, On-Treatment Levels and Dynamic Changes of Genomic Instability in Circulating Tumor DNA Predict Response to Treatment and Outcome in Metastatic Breast Cancer PatientsAdriana Aguilar-Mahecha, Josiane Lafleur, Susie Brousse, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 8, 2023
Predictors of nodal metastases in early stage HER2+ breast cancer: Deciding on treatment approach with neoadjuvant chemotherapy vs. upfront surgerySohayb Faleh, Ipshita Prakash, Elisheva Eisenberg, et al.
Pageof 13

Showing results (41-50 of 130) with videos related to

Sort By:
Pageof 13
Breast Cancer Research and Treatment|September 23, 2016
Inhibition of EGFR, HER2, and HER3 signaling with AZD8931 in combination with anastrozole as an anticancer approach: Phase II randomized study in women with endocrine-therapy-naïve advanced breast cancerStephen Johnston, Mark Basik, Roberto Hegg, et al.
Journal of Proteome Research|February 7, 2015
Glycoproteomic comparison of clinical triple-negative and luminal breast tumorsJennifer J Hill, Tammy-Lynn Tremblay, François Fauteux, et al.
Frontiers in Pharmacology|October 19, 2011
Resistance to cancer treatment: the role of somatic genetic events and the challenges for targeted therapiesGerald Batist, Jian Hui Wu, Alan Spatz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 3, 2019
A Study of Pre-Analytical Variables and Optimization of Extraction Method for Circulating Tumor DNA Measurements by Digital Droplet PCRLuca Cavallone, Mohammed Aldamry, Josiane Lafleur, et al.
Cancer|December 17, 2021
Clinicopathologic features of breast cancers diagnosed in women treated with prior radiation therapy for Hodgkin lymphoma: Results from a population-based cohortStephanie M Wong, Lissa Ajjamada, Anna C Weiss, et al.
Annals of Surgical Oncology|October 23, 2020
Oncologic Safety of Sentinel Lymph Node Biopsy Alone After Neoadjuvant Chemotherapy for Breast CancerStephanie M Wong, Mark Basik, Livia Florianova, et al.
Annals of Surgical Oncology|August 3, 2017
Nonoperative Management for Invasive Breast Cancer After Neoadjuvant Systemic Therapy: Conceptual Basis and Fundamental International Feasibility Clinical TrialsHenry M Kuerer, Marie-Jeanne T F D Vrancken Peeters, Daniel W Rea, et al.
Human Mutation|February 5, 2013
Making sense of intratumor genetic heterogeneity: altered frequency of androgen receptor CAG repeat length variants in breast cancer tissuesBruce Gottlieb, Carlos Alvarado, Chunlin Wang, et al.
Cancers|April 3, 2021
Early, On-Treatment Levels and Dynamic Changes of Genomic Instability in Circulating Tumor DNA Predict Response to Treatment and Outcome in Metastatic Breast Cancer PatientsAdriana Aguilar-Mahecha, Josiane Lafleur, Susie Brousse, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 8, 2023
Predictors of nodal metastases in early stage HER2+ breast cancer: Deciding on treatment approach with neoadjuvant chemotherapy vs. upfront surgerySohayb Faleh, Ipshita Prakash, Elisheva Eisenberg, et al.
Pageof 13